Sign inJoin waitlistJoin the waitlist

Ivan Maillard

Head of the Division of Hematologic Malignancies · New York Presbyterian Hospital

Credentials: · · · · · ·

History

Division of Hematologic Malignancies · New York Presbyterian Hospital
Present
Hematologic Malignancies Division · New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present

Hematology and Medical Oncology
University of Pennsylvania
1996–1999
University of Lausanne, Switzerland
1993–1996
University of Lausanne, Switzerland
UNIV DE LAUSANNE, FAC DE MED, LAUSANNE, SWITZERLAND
1989–1993

Research

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
Journal of Clinical Oncology · 2002 · 649 citations
Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells
Development · 2012 · 474 citations
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
Nature Medicine · 2021 · 433 citations

Warren Pear
24 papers
Bruce Blazar
21 papers
EP
Eric Perkey
20 papers · 3 as a fellow
Geoffrey Hill
14 papers
Jonathan Serody
14 papers
Joshua Brandstadter
12 papers · 2 as a fellow
MJ
Morgan Jones
11 papers · 4 as a resident
Corey Cutler
10 papers
David Munn
10 papers
Jerome Ritz
10 papers
John Koreth
10 papers
Jon Aster
10 papers

Grants

Hematology Clinical Research Training Program
National Heart, Lung, and Blood Institute · T32
PI · $969.8K · University of Pennsylvania
1979–2029
Notch Ligands as Oncogenic Drivers and Therapeutic Targets in T-Cell Lymphomas
National Cancer Institute · R01
PI · $1.9M · University of Michigan at Ann Arbor
2024–2028
Notch Signaling in Alloimmunity
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $5.2M · University of Pennsylvania
2011–2026
Cancer Center Research Training Program
National Cancer Institute · T32
PI · $2.3M · University of Pennsylvania
1988–2025